At the start of COVID19 pandemic five years ago, people who have Down’s syndrome were recognised as being more vulnerable to becoming seriously unwell from the COVID virus. They were prioritised for early access to a COVID vaccine and, in subsequent years, an autumn COVID booster.
The Governments of the nations of the UK follow independent advice from the Joint Committee on Vaccination and Immunisation (JCVI). The Committee has recently recommended that the vast majority of children and adults who have Down’s syndrome do not require a further COVID booster this autumn.
There are a small minority of children and adults who have Down’s syndrome who in addition to having Down’s syndrome have another medical condition, which means that they are immunosuppressed.
It is only these people who have Down’s syndrome would be eligible for an autumn COVID booster in the autumn of 2025.
This criteria includes:
- individuals undergoing chemotherapy or radiotherapy
- solid organ transplant recipients
- bone marrow or stem cell transplant recipients
- those with genetic disorders affecting the immune system (e.g. deficiencies of IRAK-4 or NEMO, complement disorder, SCID)
- someone with haematological malignancy, including leukaemia and lymphoma
- people receiving immunosuppressive or immunomodulating biological therapy
- individuals treated with or likely to be treated with high or moderate dose corticosteroids
- those receiving any dose of non-biological oral immune modulating drugs e.g. methotrexate, azathioprine, 6-mercaptopurine or mycophenolate
- anyone with auto-immune diseases who may require long term immunosuppressive treatments
- children who are about to receive planned immunosuppressive therapy.
Please remember that most individuals who have Down’s syndrome are recommended to have the winter flu vaccination. This can be arranged through your GP.
Anyone requiring additional information is welcome to call our helpline on 0333 12 12 300 for a discussion.
Find more background information on immunisations here.
